Group One Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20
Closed -$1K 8927
2021
Q4
$1K Buy
+20
New +$1.34K ﹤0.01% 8060
2018
Q3
Sell
-185
Closed -$14K 5719
2018
Q2
$14K Hold
185
﹤0.01% 4520
2018
Q1
$16K Hold
185
﹤0.01% 4167
2017
Q4
$137K Buy
+185
New +$71.4K ﹤0.01% 3171
2017
Q3
Sell
-25
Closed -$6K 5257
2017
Q2
$6K Sell
25
-76
-75% -$20.4K ﹤0.01% 4384
2017
Q1
$34K Sell
101
-93
-48% -$43.1K ﹤0.01% 3631
2016
Q4
$116K Sell
194
-271
-58% -$286K ﹤0.01% 2756
2016
Q3
$526K Sell
465
-25
-5% -$27K 0.01% 1783
2016
Q2
$537K Sell
490
-1
-0.2% -$1.26K 0.01% 1686
2016
Q1
$630K Buy
491
+276
+128% +$393K 0.01% 1518
2015
Q4
$527K Sell
215
-144
-40% -$221K 0.01% 1784
2015
Q3
$396K Buy
359
+229
+176% +$265K 0.01% 1968
2015
Q2
$131K Buy
130
+22
+20% +$23.7K ﹤0.01% 2873
2015
Q1
$110K Buy
108
+36
+50% +$119K ﹤0.01% 2844
2014
Q4
$241K Sell
72
-143
-67% -$438K ﹤0.01% 2152
2014
Q3
$622K Buy
215
+37
+21% +$122K 0.01% 1453
2014
Q2
$678K Buy
178
+161
+947% +$606K 0.01% 1405
2014
Q1
$93K Buy
+17
New +$89.5K ﹤0.01% 3147

Other funds holding NBSE

Group One Trading's NBSE Position: Q1 2021 in Review

Group One Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2021, closing a stake of 193 shares — an estimated $35K sold.

Group One Trading first reported a position in NBSE in Q1 2014 and held it in 15 quarters. The position peaked at $322K in Q1 2014. 56 funds tracked by Wall St. Rank hold NBSE as of Q1 2021.

  • Group One Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 193 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $35K.
  • Group One Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2014 and held it in 15 quarters.
  • Group One Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $322K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.